{"title":"Regulatory Aspects in Using Surrogate Markers in Clinical Trials","authors":"Aloka G Chakravarty","doi":"10.1007/0-387-27080-9_3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":375789,"journal":{"name":"The Evaluation of Surrogate Endpoints","volume":"57 1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Evaluation of Surrogate Endpoints","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/0-387-27080-9_3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
